Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.

about

Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.

Item

http://www.wikidata.org/entity/Q39074109

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@en

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@nl

type

Item

label

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@en

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@nl

prefLabel

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@en

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@nl

P1476

Novel Antiretroviral Drugs in ...... harmacokinetic Considerations.

@en

P2093

Cristina Gervasoni

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients

HIV and chronic kidney disease

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

Advances in the pathogenesis of HIV-associated kidney diseases.

Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients

Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients

The use of antiretroviral agents in patients with renal insufficiency.

P2888

s13318-016-0394-6

P304

559-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13318-016-0394-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dario Cattaneo

P577

2017-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28064418

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug